Correlation Between Eliem Therapeutics and Gain Therapeutics
Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Gain Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Gain Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eliem Therapeutics and Gain Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Gain Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Gain Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Gain Therapeutics.
Diversification Opportunities for Eliem Therapeutics and Gain Therapeutics
-0.49 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Eliem and Gain is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Gain Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gain Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Gain Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gain Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Gain Therapeutics go up and down completely randomly.
Pair Corralation between Eliem Therapeutics and Gain Therapeutics
Given the investment horizon of 90 days Eliem Therapeutics is expected to generate 0.85 times more return on investment than Gain Therapeutics. However, Eliem Therapeutics is 1.18 times less risky than Gain Therapeutics. It trades about -0.21 of its potential returns per unit of risk. Gain Therapeutics is currently generating about -0.21 per unit of risk. If you would invest 383.00 in Eliem Therapeutics on September 1, 2024 and sell it today you would lose (79.00) from holding Eliem Therapeutics or give up 20.63% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 95.24% |
| Values | Daily Returns |
Eliem Therapeutics vs. Gain Therapeutics
Performance |
| Timeline |
| Eliem Therapeutics |
| Gain Therapeutics |
Eliem Therapeutics and Gain Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Eliem Therapeutics and Gain Therapeutics
The main advantage of trading using opposite Eliem Therapeutics and Gain Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Gain Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gain Therapeutics will offset losses from the drop in Gain Therapeutics' long position.| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
| Gain Therapeutics vs. Tff Pharmaceuticals | Gain Therapeutics vs. Eliem Therapeutics | Gain Therapeutics vs. Inhibrx | Gain Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |